Page last updated: 2024-08-17

calcium acetate and Hypercalcemia

calcium acetate has been researched along with Hypercalcemia in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's5 (55.56)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alfieri, T; Anum, EA; Braunhofer, P; Newsome, B; Ramakrishnan, K; Wang, S1
Galani, VJ; Prajapati, VA; Shah, PR1
Craig, JC; Elder, GJ; Navaneethan, SD; Palmer, SC; Strippoli, GF1
Chen, YM; Chiang, WC; Chu, TS; Huang, CY; Huang, JW; Hung, KY; Kan, WC; Kao, TW; Lin, SL; Lin, YF; Tsai, TJ; Wu, KD; Wu, MS; Yen, CJ1
Binswanger, U; Hess, B1
Cleveland, M1
Cleveland, MV; Garza, RO; He, DY; Hootkins, RE; McDowell, LL; Meyer, MS; Muenz, LR; Nolan, CR; Pelham, RW; Qunibi, WY; Simon, M1
Chou, CY; Huang, CC; Kuo, HL; Liao, PY; Lin, HH; Lin, PW; Liu, JH; Liu, YL; Yang, YF; Yu, CC1
Albu, AT; Dungaciu, M; El Esper, N; Fournier, A; Mornière, P; Oprisiu, R1

Reviews

1 review(s) available for calcium acetate and Hypercalcemia

ArticleYear
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2009, Volume: 54, Issue:4

    Topics: Acetates; Biomarkers; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hypercalcemia; Hyperphosphatemia; Lanthanum; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Research Design; Sevelamer

2009

Trials

3 trial(s) available for calcium acetate and Hypercalcemia

ArticleYear
Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2010, Volume: 109, Issue:9

    Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Asian People; Biomarkers; Bone Remodeling; Calcium Compounds; Calcium Phosphates; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Treatment Outcome

2010
Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study).
    Kidney international, 2004, Volume: 65, Issue:5

    Topics: Acetates; Adult; Aged; Bicarbonates; Calcium; Calcium Compounds; Double-Blind Method; Epoxy Compounds; Female; Humans; Hypercalcemia; Hypocalcemia; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Polyethylenes; Prospective Studies; Renal Dialysis; Sevelamer

2004
A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients.
    Renal failure, 2006, Volume: 28, Issue:8

    Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Analysis of Variance; Biomarkers; Bone Remodeling; Calcium; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Research Design; Sevelamer; Treatment Outcome

2006

Other Studies

5 other study(ies) available for calcium acetate and Hypercalcemia

ArticleYear
Reasons for phosphate binder discontinuation vary by binder type.
    Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2014, Volume: 24, Issue:2

    Topics: Acetates; Adult; Aged; Calcium Compounds; Female; Gastrointestinal Tract; Humans; Hypercalcemia; Hypophosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Medication Adherence; Middle Aged; Phosphates; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Treatment Outcome; United States

2014
A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2014, Volume: 25, Issue:3

    Topics: Acetates; Adult; Biomarkers; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Time Factors; Treatment Outcome

2014
Long-term administration of calcium acetate efficiently controls severe hyperphosphataemia in haemodialysis patients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1990, Volume: 5, Issue:8

    Topics: Acetates; Adult; Calcium; Calcium Compounds; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Diseases; Male; Middle Aged; Phosphates; Renal Dialysis; Young Adult

1990
Calcium on trial: beyond a reasonable doubt?
    Kidney international, 2003, Volume: 63, Issue:1

    Topics: Acetates; Calcium; Calcium Carbonate; Calcium Compounds; Humans; Hypercalcemia; Kidney Failure, Chronic; Renal Dialysis

2003
The crossover comparative trial of calcium acetate versus sevelamer hydrochloride (Renagel) as phosphate binders in dialysis patients.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 35, Issue:6

    Topics: Acetates; Calcifediol; Calcinosis; Calcium; Calcium Compounds; Capsules; Cardiovascular Diseases; Cross-Over Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Sevelamer

2000